Human antibody–Fc receptor interactions illuminated by crystal structures

@article{Woof2004HumanAR,
  title={Human antibody–Fc receptor interactions illuminated by crystal structures},
  author={Jenny M. Woof and Dennis R. Burton},
  journal={Nature Reviews Immunology},
  year={2004},
  volume={4},
  pages={89-99}
}
  • J. Woof, D. Burton
  • Published 1 February 2004
  • Biology, Medicine
  • Nature Reviews Immunology
Immunoglobulins couple the recognition of invading pathogens with the triggering of potent effector mechanisms for pathogen elimination. Different immunoglobulin classes trigger different effector mechanisms through interaction of immunoglobulin Fc regions with specific Fc receptors (FcRs) on immune cells. Here, we review the structural information that is emerging on three human immunoglobulin classes and their FcRs. New insights are provided, including an understanding of the antibody… 
Immunoglobulin–Fc Receptor Interactions
Publisher Summary Immunoglobulins play a central role in immune protection. They serve as flexible adaptor molecules capable of coupling the recognition of antigenic structures on foreign
Immunoglobulins and their receptors, and subversion of their protective roles by bacterial pathogens.
  • J. Woof
  • Biology, Medicine
    Biochemical Society transactions
  • 2016
TLDR
All the Ig-binding proteins studied in detail to date are seen to target the CH2-CH3 domain interface in the Ig Fc region, suggesting a common mode of immune evasion.
Affimer proteins inhibit immune complex binding to FcγRIIIa with high specificity through competitive and allosteric modes of action
TLDR
The identification of functionally specific protein-based inhibitors (Affimer proteins) of FcγRIIIa and the structural/functional basis of their selectivity suggest that highly selective protein- based blocking agents that may have therapeutic applications can be readily produced.
CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity
TLDR
Virus-encoded FcγRs are discussed as the first known HCMV inhibitors of IgG-mediated immunity which could account for the limited efficacy of H CMV hyperimmune globulin in clinical settings and a better understanding of their molecular mode of action opens up new perspectives for improving IgG therapies against HCMv disease.
Isotype and glycoform selection for antibody therapeutics.
  • R. Jefferis
  • Biology, Medicine
    Archives of biochemistry and biophysics
  • 2012
TLDR
This review focuses on the structure and function of the Fc region of IgG molecules that mediates biologic functions, within immune complexes, by interactions with cellular Fc receptors (FcγR), and the C1q component of complement.
Cutting Edge: Human FcRL4 and FcRL5 Are Receptors for IgA and IgG
TLDR
Given their expression on activated B cells and potential for inhibitory signaling, Fc RL4 and FcRL5 are likely to be important for immune complex-dependent human B cell regulation, and they represent novel therapeutic targets for receptor blockade therapies.
The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity
TLDR
FcαRI acts as a regulator between anti- and proinflammatory responses of IgA, and its multifaceted role in immunity will be the focus of this review.
Antibody–receptor interactions mediate antibody-dependent cellular cytotoxicity
TLDR
This work provides the first solution-phase evidence that an IgG1 bearing an afucosylated Fc region appears to require fewer conformational changes for FcγRIIIa binding, and demonstrates that the Fab provides a third component that influences IgG–Fc receptor biology.
Identification of a linear epitope for Fc-binding in the mouse FcγRIII
TLDR
The effective peptide (119)SFFHNEKSVRYH(130) located in the putative C-C' loop of the EC2 domain was found to bind mouse IgG specifically with an affinity of approximately 5.58 x 10(-5) M and inhibit the binding ofmouse IgG to the receptor.
Fc Protein Engineering
TLDR
The profile of IgG-Fc ligand binding specificities is being extended through the generation and selection among multiple IgG -Fc mutant proteins, which extends possible production vehicles to include prokaryotic systems, although an increased potential for inducing anti-drug antibodies may be a limiting factor.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 124 REFERENCES
Crystal structure of the human leukocyte Fc receptor, FcγRIIa.
Fcγ receptors bind IgG to initiate cellular responses against pathogens and soluble antigens. We have determined the three–dimensional structure of the extracellular portion of human FcγRIIa to 2.0 Å
Recognition of immunoglobulins by Fcγ receptors
TLDR
Subtype specificities of FcgammaRIII receptor probably are determined by the length of the lower hinge regions of immunoglobulins, but not their amino acid composition as revealed by the binding study of theLower hinge peptides.
Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease.
TLDR
Expansion in knowledge of structure-function relationships among Fc gammaR has identified them as heritable risk factors for disease susceptibility and valuable targets for therapeutic modulation of the immune system.
Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.
TLDR
The obtained models are consistent with the observed biochemical data and may explain the observed specificity and affinities of Fcgamma-receptors.
Crystal structure of the extracellular domain of a human Fc gamma RIII.
TLDR
The crystal structure of a human immunoglobulin receptor, FcgammaRIIIb, has been determined and two separate parallel dimers are observed in the crystal lattice, offering intriguing models for receptor aggregation.
Localization of the binding site for the human high-affinity Fc receptor on IgG
TLDR
This work has engineered a single amino acid change in a mouse IgG2b antibody which enables the antibody to bind to the FcRI (high affinity) receptor on human monocytes with a 100-fold improvement in affinity, indicating that Leu 235 is a major determinant in the binding of antibody to F cRI.
The IgG Binding Site of Human FcRIIIB Receptor Involves CC′ and FG Loops of the Membrane-proximal Domain (*)
TLDR
The IgG binding site on human FcRIII is defined and residues map on the CC′ loop, on F β-sheet, and on the FG loop (Lys, Val) are found, suggesting that common structural determinants, i.e. FG loop or the GFC surface of the membrane-proximal domain, can be involved in interactions with IgG by both low affinity receptor classes F cRII and Fc RIII.
Interaction of Human IgE with Fc Epsilon RI Alpha Exposes Hidden Epitopes on IgE
TLDR
The hypothesis of a conformational change within IgE Cε3 upon receptor binding is supported by showing that monoclonal antibodies raised against recombinant C ε3 differently recognize soluble and receptor–bound IgE.
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.
TLDR
It is observed that the removal of sugar residues permits the mutual approach of Cgamma2 domains resulting in the generation of a "closed" conformation in the IgG-Fc, which may be optimal for FcgammaR binding.
The Interaction of FcαRI with IgA and Its Implications for Ligand Binding by Immunoreceptors of the Leukocyte Receptor Cluster1
TLDR
In this FcαRI model the residues forming the IgA binding site identified by mutagenesis form a single face near the N-terminus of the receptor, distinct from other leukocyte Fc receptors where ligand binding is in the second domain.
...
1
2
3
4
5
...